Recombinant proteins in the diagnosis of toxoplasmosis

APMIS

Volumn 118, Issue 8, 2010, Pages 529-542

  Kotresha, Dupadahalli ^a   Noordin, Rahmah ^a  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

Author keywords

recombinant proteins; serodiagnosis; Toxoplasma gondii; toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEMBRANE ANTIGEN; PROTEIN GRA1; PROTEIN GRA2; PROTEIN GRA4; PROTEIN GRA6; PROTEIN GRA7; PROTEIN GRA8; PROTEIN MIC2; PROTEIN MIC3; PROTEIN MIC4; PROTEIN MIC5; PROTEIN ROP1; PROTEIN ROP2; PROTEIN SAG1; PROTEIN SAG2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

CONGENITAL TOXOPLASMOSIS; DIAGNOSTIC ACCURACY; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TOXOPLASMOSIS;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; PREGNANCY; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SEROLOGIC TESTS; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 77954732199     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02629.x     Document Type: Review

References (105)

1. Blader IJ, Saeij JP. Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. APMIS 2009 117 : 458 476.
2. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998 11 : 267 299.
3. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000 30 : 1217 1258.
4. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004 363 : 1965 1976.
5. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In : Remington JS, Klein J, Wilson CB, Baker MD editors. Infectious Disease of the Fetus and Newborn Infant.
6. Dlugonska H. Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. J Biomed Biotechnol 2008 2008 : 632424.
7. Remington JS, McLeod R, Thuillez P, Desmonts G. Toxoplasmosis. In : Remington JS, Klein J editors. Infectious Diseases of the Fetus and Newborn Infant, 5th edn.
8. Sukthana Y. Toxoplasmosis: beyond animals to humans. Trends Parasitol 2006 22 : 137 142.
9. Wong SY, Remington JS. Toxoplasmosis in pregnancy. Clin Infect Dis 1994 18 : 853 861.
10. Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med 2007 120 : 911.e1 8.
11. Santoni JR, Santoni-Williams CJ. Headache and painful lymphadenopathy in extracranial or systemic infection: etiology of new daily persistent headaches. Intern Med 1993 32 : 530 532.
12. Beghetto E, Spadoni A, Bruno L, Buffolano W, Gargano N. Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products. J Clin Microbiol 2006 44 : 2133 2140.
13. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 2002 185 : S73 82.
14. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004 42 : 941 945.
15. Bobic B, Sibalic D, Djurkovic-Djakovic O. High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Gynecol Obstet Invest 1991 31 : 182 184.
16. Gorgievski-Hrisoho M, Germann D, Matter L. Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii. J Clin Microbiol 1996 34 : 1506 1511.
17. Meek B, Diepersloot RJ, van Gool T, Speijer D, Peek R. IgM recognition of recombinant Toxoplasma gondii antigens by sera of acutely or latently infected humans. Diagn Microbiol Infect Dis 2003 45 : 45 52.
18. Gutierrez J, Rodriguez M, Piedrola G, del Carmen Maroto M. Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis. Clin Microbiol Infect 1997 3 : 658 662.
19. Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989 159 : 736 740. (Pubitemid 19105628)
20. de Ory F, Casas I, Domingo CJ, Echevarria J. Application of fluoroimmunoassay to the identification of low avidity specific IgG against pathogenic human viruses and Toxoplasma gondii. Clin Diagn Virol 1995 3 : 323 332.
21. Holliman RE, Raymond R, Renton N, Johnson JD. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect 1994 112 : 399 408.
22. Paul M. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clin Diagn Lab Immunol 1999 6 : 514 518.
23. Joynson DH, Payne RA, Rawal BK. Potential role of IgG avidity for diagnosing toxoplasmosis. J Clin Pathol 1990 43 : 1032 1033.
24. Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita 2004 40 : 81 8.
25. Logar J, Novak-Antolic Z, Zore A. Specific IgG avidity - a supplementary assay in serological screening for toxoplasmosis in pregnancy. J Infect 1999 38 : 61 3.
26. Melo FG, Rossi CL. DOT-enzyme-linked immunosorbent assay (DOT-ELISA) for evaluating IgG antibody avidity in toxoplasmosis. Rev Inst Med Trop Sao Paulo 1997 39 : 235 236.
27. Carruthers VB. Armed and dangerous: Toxoplasma gondii uses an arsenal of secretory proteins to infect host cells. Parasitol Int 1999 48 : 1 10.
28. Carruthers VB, Hakansson S, Giddings OK, Sibley LD. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun 2000 68 : 4005 4011.
29. Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC. Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS Pathog 2005 1 : e17.
30. Charron AJ, Sibley LD. Molecular partitioning during host cell penetration by Toxoplasma gondii. Traffic 2004 5 : 855 867.
31. Mordue D, Hakansson S, Niesman IR, Sibley LD. Toxoplasma gondii resides in a vacuole that resists fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp Parasitol 1999 92 : 87 99.
32. Hakansson S, Charron AJ, Sibley LD. Toxoplasma evacuoles: a two-step process of secretion and fusion forms the parasitophorous vacuole. EMBO J 2001 20 : 3132 3144.
33. Carey KL, Jongco AM, Kim K, Ward GE. The Toxoplasma gondii rhoptry protein ROP4 is secreted into the parasitophorous vacuole and becomes phosphorylated in infected cells. Eukaryot Cell 2004 3 : 1320 1330.
34. Mercier C, Dubremetz JF, Rauscher B, Lecordier L, Sibley LD, Cesbron-Delauw MF. Biogenesis of nanotubular network in Toxoplasma parasitophorous vacuole induced by parasite proteins. Mol Biol Cell 2002 13 : 2397 2409.
35. Magno RC, Lemgruber L, Vommaro RC, De Souza W, Attias M. Intravacuolar network may act as a mechanical support for Toxoplasma gondii inside the parasitophorous vacuole. Microsc Res Tech 2005 67 : 45 52.
36. Chen XG, Gong Y, Hua-Li, Lun ZR, Fung MC. High-level expression and purification of immunogenic recombinant SAG1 (P30) of Toxoplasma gondii in Escherichia coli. Protein Expr Purif 2001 23 : 33 7.
37. Holec L, Hiszczyn'ska-Sawicka E, Gasior A, Brillowska-Dabrowska A, Kur J. Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans. Clin Vaccine Immunol 2007 14 : 220 225.
38. Jacobs D, Vercammen M, Saman E. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol 1999 6 : 24 9.
39. Li S, Maine G, Suzuki Y, Araujo FG, Galvan G, Remington JS, et al. Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen. J Clin Microbiol 2000 38 : 179 184.
40. Martin V, Arcavi M, Amendoeira MRR, de Souza Neves E, Santilla'n G, Guarnera E, et al. Detection of human anti-Toxoplasma specific immunoglobulins A, M and G by a recombinant Toxoplasma gondii Rop2 protein. Clin Diagn Lab Immunol 1998 5 : 627 631.
41. Redlich A, Muller WA. Serodiagnosis of acute toxoplasmosis using a recombinant form of the dense granule antigen GRA6 in an enzymelinked immunosorbent assay. Parasitol Res 1998 84 : 700 706.
42. Suzuki Y, Ramirez R, Press C, Li S, Parmley S, Thulliez P, et al. Detection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women. J Clin Microbiol 2000 38 : 3967 3970.
43. van Gelder F, Bosman F, De Meuter F, Van Heuverswyn H, Hérion P. Serodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli. J Clin Microbiol 1993 31 : 9 15.
44. Buffolano W, Beghetto E, Del Pezzo M, Spadoni A, Di Cristina M, Petersen E, et al. Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis. J Clin Microbiol 2005 43 : 5916 5924.
45. Tomavo S, Schwarz RT, Dubremetz JF. Evidence for glycosylphosphatidylinositol anchoring of Toxoplasma gondii major surface antigens. Mol Cell Biol 1989 9 : 4576 4580.
46. Nagel SD, Boothroyd JC. The major surface antigen, P30 of Toxoplasma gondii is anchored by a glycolipid. J Biol Chem 1989 264 : 5569 5574.
47. Boothroyd JC, Hehl A, Knoll LJ, Manger ID. The surface of Toxoplasma gondii: more or less. Int J Parasitol 1998 28 : 3 9.
48. Lekutis C, Ferguson DJP, Bootthroyd JC. Toxoplasma gondii: identification of a developmentally regulated family of genes related to SAG2. Exp Parasitol 2000 96 : 89 96.
49. Manger ID, Hehl AB, Boothroyd JC. The surface of Toxoplasma tachyzoites is dominated by a family of glycosyl phosphatidylinositol anchored antigens related to SAG1. Infect Immun 1998 66 : 2237 2244.
50. Burg JL, Perelman D, Kasper L, Ware PL, Boothroyd JC. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol 1988 141 : 3584 3591.
51. Harning D, Spenter J, Metsis A, Vuust J, Petersen E. Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol 1996 3 : 355 357.
52. Mohamed RM, Aosai F, Chen M, Mun HS, Norose K, Belal US. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine 2003 21 : 2852 2861.
53. Siachoque H, Guzman F, Burgos J, Patarroyo ME, Gomez MJ. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Exp Parasitol 2006 114 : 62 5.
54. Wu K, Chen XG, Li H, Yana H, Yang PL, Lun ZR, et al. Diagnosis of human toxoplasmosis by using the recombinant truncated surface antigen 1 of Toxoplasma gondii. Diagn Microbiol Infect Dis 2009 64 : 261 266.
55. Parmley SF, Sgarlato GD, Mark J, Prince JB, Remington JS. Expression, characterization, and serologic reactivity of recombinant surface antigen p22 of Toxoplasma gondii. J Clin Microbiol 1992 30 : 1127 1133.
56. Pietkiewicz H, Hiszczyjska-Sawicka E, Kur J, Petersen E, Nielsen HV, Stankiewicz M, et al. Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol 2004 42 : 1779 1781.
57. Aubert D, Maine GT, Villena I, Hunt JC, Howard L, Sheu M. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol 2000 38 : 1144 1150.
58. Pfrepper KI, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, et al. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol 2005 12 : 977 982.
59. Gatkowska J, Hiszczyńska-Sawicka E, Kur J, Holec L, Dlugonska H. Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model. Exp Parasitol 2006 114 : 220 227.
60. Chen XG, Liu GZ, Xu F, Wang XZ, Jiang JB. Amplification, cloning, sequencing and expression of the gene encoding the major surface antigen of Toxoplasma gondii isolated in China. J Med Coll PLA 1994 9 : 98 101.
61. Li S, Galvan G, Araujo FG, Suzuki Y, Remington J, Parmley S. Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens. Clin Diagn Lab Immunol 2000 7 : 781 787.
62. Prince JB, Auer KL, Kuskinson J, Parmley SF, Araujo FG, Remington JS. Cloning, expression, and cDNA sequence of surface antigen P22 from Toxoplasma gondii. Mol Biochem Parasitol 1990 43 : 97 106.
63. Hiszczyjska-Sawicka E, Kur J, Pietkiewicz H, Holec L, Gasior A, Myjak P. Efficient production of the Toxoplasma gondii GRA6, p35 and SAG2 recombinant antigens and their applications in the serodiagnosis of toxoplasmosis. Acta Parasitol 2005 50 : 249 254.
64. Ling Lau Y, Yik Fong M. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris. Exp Parasitol 2008 119 : 373 378.
65. Béla SR, Oliveira Silva DA, Cunha-Júnior JP, Pirovani CP, Chaves-Borges FA, de Carvalho FR. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies. Diagn Microbiol Infect Dis 2008 62 : 245 254.
66. Parmley SF, Yang S, Harth G, Sibley LD, Sucharczuk A, Remington JS. Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol Biochem Parasitol 1994 66 : 283 296. (Pubitemid 24272075)
67. Ferguson DJ, Parmley SF. Toxoplasma gondii MAG1 protein expression. Trends Parasitol 2002 18 : 482.
68. Mercier C, Adjogble KD, Daubener W, Delauw MF. Dense granules: are they key organelles to help understand the parasitophorous vacuole of all Apicomplexa parasites? Int J Parasitol 2005 35 : 829 849.
69. Hughes HP, Van Knapen F. Characterization of a secretory antigen from Toxoplasma gondii and its role in circulating antigen production. Int J Parasitol 1982 12 : 433 437.
70. Golkar M, Rafati S, Abdel-Latif MS, Brenier-Pinchart MP, Fricker-Hidalgo H, Sima BK. The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women. Diagn Microbiol Infect Dis 2007 58 : 419 426.
71. Pietkiewicz H, Hiszczyńska-Sawicka E, Kur J, Petersen E, Nielsen HV, Paul M, et al. Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis. Parasitol Res 2007 100 : 333 337.
72. Babaie J, Zare M, Sadeghiani G, Lorgard-Dezfuli M, Aghighi Z, Golkar M. Bacterial production of dense granule antigen GRA8 of Toxoplasma gondii. Iran Biomed J 2009 13 : 145 151.
73. Mercier C, Cesbron-Delauw MF, Ferguson DJP. Dense granules of the infectious stages of Toxoplasma gondii: their central role in the host/parasite relationship. In : Soldati D, Ajioka J editors. Toxoplasma: Molecular and Cellular Biology.
74. Cesbron-Delauw MF, Guy B, Torpier G, Pierce RJ, Lenzen G, Cesbron JY, et al. Molecular characterization of 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci USA 1989 86 : 7537 7541.
75. Ferrandiz J, Mercier C, Wallon M, Picot S, Cesbron-Delauw MF, Peyron F. Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women. Clin Diagn Lab Immunol 2004 11 : 1016 1021.
76. Holec-Gasior L, Kur J, Hiszczyn'ska-Sawicka E. GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis. Clin Vaccine Immunol 2009 16 : 510 514.
77. Murray A, Mercier C, Decoster A, Lecordier L, Capron A, Cesbron-Delauw MF. Multiple B-cell epitopes in a recombinant GRA2 secreted antigen of Toxoplasma gondii. Appl Parasitol 1993 34 : 235 244.
78. Lecordier L, Fourmaux MP, Mercier C, Dehecq E, Masy E, Cesbron-Delauw MF. Enzyme-linked immunosorbent assay using recombinant dense granule antigens GRA6 and GRA1 of Toxoplasma gondii for detection of immunoglobulin G antibodies. Clin Diagn Lab Immunol 2000 7 : 607 611.
79. Hiszczyjska-Sawicka E, Brillowska-Dabrowska A, Dabrowski S, Pietkiewicz H, Myjak P, Kur J. High yield expression and single step purification of Toxoplasma gondii SAG1, GRA1, and GRA7 antigens in Escherichia coli. Protein Expr Purif 2003 27 : 150 157.
80. Nigro M, Gutierrez A, Hoffer AM, Clemente M, Kaufer F, Carral L. Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagn Microbiol Infect Dis 2003 47 : 609 613.
81. Beghetto E, Buffolano W, Spadoni A, Del Pezzo M, Di Cristina M, Minenkova O, et al. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol 2003 41 : 5414 5418.
82. Golkar M, Azadmanesh K, Khalili G, Khoshkholgh-Sima B, Babaie J, Mercier C. Serodiagnosis of recently acquired Toxoplasma gondii infection in pregnant women using enzyme-linked immunosorbent assays with a recombinant dense granule GRA6 protein. Diagn Microbiol Infect Dis 2008 61 : 31 9.
83. Sickinger E, Gay-Andrieu F, Jonas G, Schultess J, Stieler M, Smith D. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diagn Microbiol Infect Dis 2008 62 : 235 244.
84. Bobic′ B, Klun I, Vujanic′ M, Nikolic′ A, Ivovic′ V, Ž ivkovic′ T, et al. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J Med Microbiol 2009 58 : 358 364.
85. Araujo PRB, Ferreira AW. Avidity of IgG antibodies against excreted/secreted antigens of Toxoplasma gondii: immunological marker for acute recent toxoplasmosis. Rev Soc Bras Med 2008 41 : 142 147.
86. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994 18 : 38 72.
87. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994 330 : 1858 1863.
88. Koppe JG, Loewer-Sieger DH, De Roever-Bonnet H. Results of 20 year follow-up of congenital toxoplasmosis. Lancet 1986 101 : 254 257.
89. Lappalainen M, Koskiniemi M, Hilesmaa V, Ammala P, Teramo K, Koskela P. Outcome of children after maternal primary infection during pregnancy with emphasis on avidity of specific IgG. Pediatr Infect Dis J 1995 14 : 354 361.
90. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for Toxoplasma infection in the absence of prenatal treatment. Lancet 1999 353 : 1834 1837.
91. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynaecol 1999 180 : 410 415.
92. Petersen E, Pollak A, Reiter-Owona I. Recent trends in research on congenital toxoplasmosis. Int J Parasitol 2001 31 : 115 144.
93. Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Scand J Infect Dis 1998 30 : 295 300.
94. Buffolano W, Lappalainen M, Hedman L, Ciccimarra F, Del Pezzo M, Rescaldani R. Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2004 23 : 825 830.
95. Candolfi E, Bessieres MH, Mart P, Cimon B, Gandilhon F, Pelloux H, et al. Determination of a new cut-off value for the diagnosis of congenital toxoplasmosis by detection of specific IgM in an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 1993 12 : 396 398.
96. Fricker-Hidalgo H, Pelloux H, Racinet C, Bost M, Goullier-Fleuret A, Ambroise-Thomas P. Congenital toxoplasmosis: specific IgM in fetal blood, cord blood and in the newborn. Ann Biol Clin 1996 54 : 165 168.
97. Chumpitazi BF, Boussaid A, Pelloux H, Racinet C, Bost M, Goullier-Fleuret A. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. J Clin Microbiol 1995 33 : 1479 1485.
98. Gross U, Luder CG, Hendgen V, Heeg C, Sauer I, Weidner A. Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis. J Clin Microbiol 2000 38 : 3619 3622.
99. Nielsen HV, Schmidt DR, Petersen E. Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child immunoglobulin g profiles. J Clin Microbiol 2005 43 : 711 715.
100. Pinon JM, Chemla C, Villena I, Foudrinier F, Aubert D, Puygauthier-Toubas D, et al. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol 1996 34 : 579 583.
101. Pinon JM, Dumon H, Chemla C, Franck J, Petersen E, Lebech M, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001 39 : 2267 2271.
102. Remington JS, Araujo FG, Desmonts G. Recognition of different Toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns. J Infect Dis 1985 152 : 1020 1024.
103. Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol 1999 37 : 2893 2898.
104. Altcheh J, Diaz NS, Pepe CM, Martin V, Nigro M, Freilija H, et al. Kinetic analysis of the humoral immune response against 3 Toxoplasma gondii-recombinant proteins in infants with suspected congenital toxoplasmosis. Diagn Microbiol Infect Dis 2006 56 : 161 165.
105. Holec L, Gasior A, Brillowska-Dabrowska, Kur J. Toxoplasma gondii: enzyme-linked immunosorbent assay using different fragments of recombinant microneme protein1 (MIC1) for detection of immunoglobulin G antibodies. Exp Parasitol 2008 119 : 1 6.